Biden Administration Expects To Win Fight Over Medicare Drug Negotiations

White House domestic policy adviser Neera Tanden said Sunday that she’s convinced that the Inflation Reduction Act’s Medicare drug price negotiation program will be upheld in court.

Speaking on “The Katie Phang Show” on MSNBC, Tanden said, “There is nothing in the Constitution that stops Medicare from negotiating drug prices. We really, we feel very strongly about our ability to win these lawsuits because this is just a basic principle.”

On Tuesday, the federal government announced the first 10 drugs that will be subject to price negotiations between Medicare and and pharmaceutical companies, including drugs that treat diabetes, heart failure and blood clots.

But drug makers and trade associations have filed multiple lawsuits challenging the program, which is designed to lower costs for Medicare patients.

“Everybody negotiates prices,” Tanden told Phang. “What the pharmaceutical companies are doing are they’re going to the courts to ensure that they can charge any price they can get away with, and that is wrong.”

Tanden also said she expects the program to be expanded, with 15 or 20 drugs added in future installments.

“It’s really important to remember that for medications that aren’t on this list, they may be on future lists,” she said, noting that “prices have been lowered already for insulin.”


Source Link

Recommended Articles

Federal Court Hears First Oral Arguments In Legal Battle Over Medicare Negotiation

The Southern District Court of Ohio on Friday heard oral arguments from the federal government and the Chamber of Commerce in the latter’s lawsuit challenging the Medicare Drug Price Negotiation Program, with both sides rehashing long-held assertions. The Chamber has requested that the Medicare negotiation program be blocked from operating, with the organization asking for ...

Read More

Low-Income Seniors Report Deceptive Medicare Marketing: Study

Seniors are becoming increasingly overburdened by marketing efforts from private Medicare plans, and low-income beneficiaries are twice as likely to file complaints regarding fraudulent phone calls compared to high-income counterparts, according to a study from The Commonwealth Fund. The study found that 22% of low-income adults report receiving fraudulent calls, while just 10% of higher-income individuals report ...

Read More

Beneficiaries Switching From Traditional Medicare Helped Fuel Huge Growth In MA

Much of the growth experienced by Medicare Advantage over the last two decades can be attributed to beneficiaries switching from traditional Medicare to MA, a trend that’s accelerated in recent years, according to a study published today in Health Affairs. “We found that switching from fee-for-service Medicare into MA, particularly by younger and healthier beneficiaries, has driven the increased ...

Read More

Humana Sues Feds Over Medicare Advantage Risk Adjustment Changes

Humana has filed suit against the feds, saying the Biden administration’s bid to claw back overpayments in Medicare Advantage (MA) is built on “shifting justifications and erroneous legal reasoning.” Earlier this year, the Centers for Medicare & Medicaid Services (CMS) finalized a hotly anticipated rule that would overhaul risk adjustment data validation (RADV) audits, which determine whether ...

Read More